paper-with-me

Papers

Decomposed Direct Preference Optimization for Structure-Based Drug Design

2024-07-19 · Xiwei Cheng, Xiangxin Zhou, Yuwei Yang, Yu Bao, Quanquan Gu

Diffusion models have achieved promising results for Structure-Based Drug Design (SBDD). Nevertheless, high-quality protein subpocket and ligand data are relatively scarce, which hinders the models' generation capabilities. Recently, Direct Preference Optimization (DPO) has emerged as a pivotal tool for aligning generative models with human preferences. In this paper, we propose DecompDPO, a structure-based optimization method aligns diffusion models with pharmaceutical needs using multi-granularity preference pairs. DecompDPO introduces decomposition into the optimization objectives and obtains preference pairs at the molecule or decomposed substructure level based on each objective's decomposability. Additionally, DecompDPO introduces a physics-informed energy term to ensure reasonable molecular conformations in the optimization results. Notably, DecompDPO can be effectively used for two main purposes: (1) fine-tuning pretrained diffusion models for molecule generation across various protein families, and (2) molecular optimization given a specific protein subpocket after generation. Extensive experiments on the CrossDocked2020 benchmark show that DecompDPO significantly improves model performance, achieving up to 95.2% Med. High Affinity and a 36.2% success rate for molecule generation, and 100% Med. High Affinity and a 52.1% success rate for molecular optimization.

📄 PDF Abstract BibTeX arXiv:2407.13981

Code (0)

등록된 구현이 없습니다.

Tasks

Drug Design

Methods 이 논문이 사용한 방법론

DPO 설명 없음
Diffusion Diffusion models generate samples by gradually removing noise from a signal, and their training objective can be expressed as a reweighted variational lower-bound…

Similar Papers 제목 키워드 기반

DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization

2024-03-07 · Xiangxin Zhou, Xiwei Cheng, Yuwei Yang, Yu Bao 외

Recently, 3D generative models have shown promising performances in structure-based drug design by learning to generate ligands given target binding sites. However, only modeling the target-ligand distribution can hardly…

Drug DesignDrug Discovery

MolChord: Structure-Sequence Alignment for Protein-Guided Drug Design

2025-10-31 · Wei Zhang, Zekun Guo, Yingce Xia, Peiran Jin 외 arxiv

Structure-based drug design (SBDD), which maps target proteins to candidate molecular ligands, is a fundamental task in drug discovery. Effectively aligning protein structural representations with molecular representatio…

Drug Discovery

Antigen-Specific Antibody Design via Direct Energy-based Preference Optimization

2024-03-25 · Xiangxin Zhou, Dongyu Xue, Ruizhe Chen, Zaixiang Zheng 외

Antibody design, a crucial task with significant implications across various disciplines such as therapeutics and biology, presents considerable challenges due to its intricate nature. In this paper, we tackle antigen-sp…

DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design

2024-02-26 · Jiaqi Guan, Xiangxin Zhou, Yuwei Yang, Yu Bao 외

Designing 3D ligands within a target binding site is a fundamental task in drug discovery. Existing structured-based drug design methods treat all ligand atoms equally, which ignores different roles of atoms in the ligan…

AvgDrug DesignDrug Discovery

Preference optimization of protein language models as a multi-objective binder design paradigm

2024-03-07 · Pouria Mistani, Venkatesh Mysore

We present a multi-objective binder design paradigm based on instruction fine-tuning and direct preference optimization (DPO) of autoregressive protein language models (pLMs). Multiple design objectives are encoded in th…

Language ModelingLanguage Modelling